Delivery Order SPE2DB22D1103-SPE2DB24FTNY7

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA), a defense agency. The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 3, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,956.18 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Lantus Solostar insulin pens. The contract has a ceiling value of $1,768.16 and a completion date of May 22, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Lantus Solostar insulin pens. The contract has a ceiling value of $1,187.60 and an ultimate completion date of April 22, 2024. This is a Delivery Order contract with a Firm Fixed Price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $1,295.20 firm fixed-price delivery order is for the supply of Lantus Solostar insulin pens, with a completion date of June 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract is a delivery order valued at $2,110.95 with a period of performance through September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, for the...
This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML insulin pens to the Defense Logistics Agency (DLA). The $1,980.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract has an ultimate completion date of December 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for Lantus Solostar insulin pens valued at $3,598.46. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $1,187.60 with a firm-fixed price. It is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, a critical medication used to manage diabetes. The award has an ultimate completion date of August 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml insulin pens to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,266.54 and a completion date of October 20, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTNY7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,310.10, is for the delivery of Lantus Solostar insulin pens with an ultimate completion date of July 24, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract is for the supply of a wide range of medical commodities, including prescription medications, vaccines, and medical supplies, to support military treatment programs and facilities worldwide. This contract award does not utilize a set-aside designation.

Generated 10/22/24, 9:17 AM